Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

NMRA

Neumora Therapeutics, Inc.

CIK 0001885522 · Nasdaq

NasdaqHealth CareBiological Products, (No Diagnostic Substances)
$1.63
↑ 0.11 (7.59%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals; Excluded: Options (no data)

Key stats

Market Cap
$306.27M
P/E Ratio
-1.44
EPS
-1.45
Dividend Yield
Not covered
52W Position
28%
Beta
0.70

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
6.88
P/S
Not covered
EV/Revenue
Not covered
ROE
-477.9%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

250 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 28%
$0.83$3.65

Latest Financials

2025-12-31 FY
Revenue
–
Net Income
-$236.93M
Total Assets
$191.05M
Free Cash Flow
–

Recent news